Oxford Immunotec Global (OXFD) Short Interest Ratio & Short Volume

Short interest is the volume of Oxford Immunotec Global shares that have been sold short but have not yet been covered or closed out. As of February 12th, investors have sold 136,500 shares of OXFD short. 0.55% of Oxford Immunotec Global's shares are currently sold short. Learn More on Oxford Immunotec Global's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.55% of Oxford Immunotec Global's floating shares are currently sold short.

Oxford Immunotec Global saw a decline in short interest in the month of February. As of February 12th, there was short interest totaling 136,500 shares, a decline of 11.0% from the previous total of 153,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Oxford Immunotec Global currently has issued a total of 25,962,000 shares. Some of Oxford Immunotec Global's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oxford Immunotec Global currently has a public float of 25,010,000 shares.

0.55% of Oxford Immunotec Global's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Oxford Immunotec Global: Achieve Life Sciences, Inc. (2.08%), ImmuCell Co. (0.08%), Aspira Women's Health Inc. (2.52%), Myriad Genetics, Inc. (6.08%), Aerovate Therapeutics, Inc. (7.15%), Absci Co. (10.01%), InnovAge Holding Corp. (1.63%), IGM Biosciences, Inc. (25.04%), Avid Bioservices, Inc. (16.26%), Iradimed Corporation (1.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.62 billion), Charter Communications, Inc. ($5.35 billion), Analog Devices, Inc. ($5.07 billion), Snap Inc. ($3.60 billion), Futu Holdings Limited ($2.92 billion), Palantir Technologies Inc. ($2.55 billion), Airbnb, Inc. ($2.52 billion), Snowflake Inc. ($2.38 billion), Peloton Interactive, Inc. ($2.22 billion), and The Kroger Co. ($2.07 billion). View all of the most shorted stocks.

Short selling OXFD is an investing strategy that aims to generate trading profit from Oxford Immunotec Global as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oxford Immunotec Global occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OXFD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OXFD, twice per month. The most recent reporting period available is February, 12 2021.